SANDOZ TERIFLUNOMIDE
SANDOZ TERIFLUNOMIDE
Approved
DIN Number
02505843
Drug Class
Human
Market Date
May 16, 2022
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505843
AIG Number0154970001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AK02 TERIFLUNOMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:04.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
TERIFLUNOMIDEActive
Strength: 14 MG
Monograph: TERIFLUNOMIDE